- Previous Close
0.0000 - Open
0.7500 - Bid 0.0001 x --
- Ask 19.2900 x 40700
- Day's Range
0.7500 - 0.7500 - 52 Week Range
0.7500 - 0.7500 - Volume
19,000 - Avg. Volume
0 - Market Cap (intraday)
384.737M - Beta (5Y Monthly) --
- PE Ratio (TTM)
25.00 - EPS (TTM)
0.0300 - Earnings Date Apr 1, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date May 23, 2024
- 1y Target Est
--
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
investors.niox.comRecent News: CSSPF
View More
Performance Overview: CSSPF
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CSSPF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CSSPF
View MoreValuation Measures
Market Cap
413.16M
Enterprise Value
401.02M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--